Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level

TNF-related apoptosis-inducing ligand or Apo2L (Apo2L/TRAIL) is a promising anti-cancer drug owing to its ability to trigger apoptosis by binding to TRAIL-R1 or TRAIL-R2, two membrane-bound receptors that are often expressed by tumor cells. TRAIL can also bind non-functional receptors such as TRAIL-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Morizot, A, Mérino, D, Lalaoui, N, Jacquemin, G, Granci, V, Iessi, E, Lanneau, D, Bouyer, F, Solary, E, Chauffert, B, Saas, P, Garrido, C, Micheau, O
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2011
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117243/
https://ncbi.nlm.nih.gov/pubmed/21072058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cdd.2010.144
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars